Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
In 2007 and 2008 in Myanmar, we detected influenza viruses A (H3N2) that exhibited reduced sensitivity to both zanamivir and amantadine. These rare and naturally occurring viruses harbored a novel Q136K mutation in neuraminidase and S31N mutation in M2.
Main Authors: | Clyde Dapat, Yasushi Suzuki, Reiko Saito, Yadanar Kyaw, Yi Yi Myint, Nay Lin, Htun Naing Oo, Khin Yi Oo, Ne Win, Makoto Naito, Go Hasegawa, Isolde C. Dapat, Hassan Zaraket, Tatiana Baranovich, Makoto Nishikawa, Takehiko Saito, Hiroshi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2010-03-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/16/3/09-1321_article |
Similar Items
-
Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
by: Katrina Sleeman, et al.
Published: (2011-11-01) -
Features of Early Diagnosis, Causal Treatment and Chemoprophylaxis of Influenza
by: O.M. Zinchuk, et al.
Published: (2013-11-01) -
Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways
by: Li Y, et al.
Published: (2018-04-01) -
Oseltamivir for the treatment of influenza in children and adolescents
by: Alfredo Tagarro, et al.
Published: (2019-05-01) -
Oseltamivir para el tratamiento de la gripe en niños y adolescentes
by: Alfredo Tagarro, et al.
Published: (2019-05-01)